- Previous Close
537.02 - Open
534.86 - Bid 538.40 x 100
- Ask 539.35 x 200
- Day's Range
534.00 - 540.13 - 52 Week Range
320.26 - 556.23 - Volume
750,986 - Avg. Volume
1,316,954 - Market Cap (intraday)
191.92B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
86.91 - EPS (TTM)
6.20 - Earnings Date Jan 21, 2025 - Jan 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
556.42
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
www.intuitive.com13,676
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ISRG
View MorePerformance Overview: ISRG
Trailing total returns as of 12/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISRG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISRG
View MoreValuation Measures
Market Cap
191.92B
Enterprise Value
187.69B
Trailing P/E
86.63
Forward P/E
69.44
PEG Ratio (5yr expected)
4.00
Price/Sales (ttm)
24.70
Price/Book (mrq)
12.32
Enterprise Value/Revenue
23.86
Enterprise Value/EBITDA
74.34
Financial Highlights
Profitability and Income Statement
Profit Margin
28.51%
Return on Assets (ttm)
7.95%
Return on Equity (ttm)
15.97%
Revenue (ttm)
7.87B
Net Income Avi to Common (ttm)
2.24B
Diluted EPS (ttm)
6.20
Balance Sheet and Cash Flow
Total Cash (mrq)
4.23B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
637.52M